Shares of Olema Pharmaceuticals OLMA have rallied 46.5% so far in September after the company announced a new collaboration agreement for its lead product candidate, palazestrant, with pharma bigwig ...

As of September 30, 2025, the average one-year price target for Olema Pharmaceuticals is $24.82/share. The forecasts range from a low of $18.18 to a high of $31.50. The average price target represents ...

Detailed price information for Olema Pharmaceuticals Inc (OLMA-Q) from The Globe and Mail including charting and trades.

H.C. Wainwright reiterated its Buy rating and $28 price target for Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) on May 29, following an update on the company continuing clinical trials. On May 28, Olema ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...